Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
31.72
-0.60 (-1.86%)
Oct 16, 2026, 9:51 AM EDT - Market open
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $1.89 billion as of October 16, 2026. It is the 6,816th most valuable company in the world and the 1,795th biggest in the United States. Its market cap has decreased by 21.23% in one year.
Market Cap
1.89B
Enterprise Value
960.08M
1-Year Change
-21.23%
Global Rank
Country Rank
#1,795 United States
Category
ChartMarket Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $1.89B, an increase of 106.07%. That is a compound annual growth rate of 5.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 1.89B | 19.31% |
| Dec 31, 2025 | 1.59B | -15.30% |
| Dec 31, 2024 | 1.87B | 50.56% |
| Dec 29, 2023 | 1.24B | -19.33% |
| Dec 30, 2022 | 1.54B | -13.57% |
| Dec 31, 2021 | 1.79B | -40.52% |
| Dec 31, 2020 | 3.00B | 6.73% |
| Dec 31, 2019 | 2.81B | 4.81% |
| Dec 31, 2018 | 2.68B | -3.76% |
| Dec 29, 2017 | 2.79B | 58.97% |
| Dec 30, 2016 | 1.75B | -28.25% |
| Dec 31, 2015 | 2.44B | -37.12% |
| Dec 31, 2014 | 3.89B | 420.55% |
| Dec 31, 2013 | 746.50M | -18.77% |
| Jul 24, 2013 | 919.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palvella Therapeutics | 1.88B |
| Mineralys Therapeutics | 1.87B |
| UroGen Pharma | 1.86B |
| Vir Biotechnology | 1.86B |
| Xencor | 1.83B |
| Mesoblast | 1.81B |
| Trevi Therapeutics | 1.79B |
| Zymeworks | 1.79B |